Dendritic cells/Cytokine-induced killer cells

N/A

Report date: 2022/09/06 18:03:08

Base Information

Drug NameDendritic cells/Cytokine-induced killer cells

Drug Alias Name树突状细胞/细胞因子诱导的杀伤细胞Dendritic cells+Cytokine-induced killer cells

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cellCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsNatural killer cells stimulants

TargetsNot applicable

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesBeijing Biohealthcare Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBeijing Biohealthcare Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A